Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Ovarian Neoplasms 17Neoplasms 6Breast Neoplasms 6Prostatic Neoplasms 4Fallopian Tube Neoplasms 4Pancreatic Neoplasms 3Triple Negative Breast Neoplasms 2Prostatic Neoplasms, Castration-Resistant 2Neoplasm Metastasis 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Stomach Neoplasms 1Prostate Adenocarcinoma 1Pancreatic Adenocarcinoma 1Osteosarcoma 1Oligodendroglioma 1Neuroblastoma 1Metastatic Castration-sensitive Prostate Cancer 1Mesothelioma 1Melanoma 1Lung Neoplasms 1Glioma 1Glioblastoma 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Ifosfamide 11Methotrexate 9Doxorubicin 7Magnetic Resonance Spectroscopy 6Filgrastim 6Cisplatin 6Leucovorin 5Etoposide 5X-Rays 4Specimen Handling 4Sirolimus 4Phantoms, Imaging 4Gemcitabine 4temsirolimus 3sargramostim 3dinutuximab 3cixutumumab 3Radiotherapy 3Nuclear Medicine Department, Hospital 3Granulocyte-Macrophage Colony-Stimulating Factor 3Dexrazoxane 3Cyclophosphamide 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2samarium Sm-153 lexidronam 2palbociclib 2olaparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Osteosarcoma × niraparib × Clear all
NCT04544995 2026-01-21

Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)

GlaxoSmithKline

Phase 1 Terminated
47 enrolled 43 charts
CNSSarcoma

Neoplasms, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡